Plasma-type gelsolin in subarachnoid hemorrhage: Novel biomarker today, therapeutic target tomorrow?

Critical Care

Volumn 18, Issue 1, 2014, Pages

  Chou, Sherry Hsiang Yi ^a,b   Lo, Eng H ^b   Ning, MingMing ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELSOLIN; MATRIX METALLOPROTEINASE;

CEREBROSPINAL FLUID; DISEASE MARKER; DISEASE SEVERITY; ENZYME DEGRADATION; HUMAN; NONHUMAN; NOTE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SUBARACHNOID HEMORRHAGE; BLOOD; FEMALE; INTRACRANIAL ANEURYSM; MALE;

FEMALE; GELSOLIN; HUMANS; INTRACRANIAL ANEURYSM; MALE; SUBARACHNOID HEMORRHAGE;

EID: 84891657035     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc13178     Document Type: Note

References (12)

1. Pan JW, He LN, Xiao F, Shen J, Zhan RY. Plasma gelsolin levels and outcomes after aneurysmal subarachnoid hemorrhage. Crit Care 2013, 17:R149. 10.1186/cc12828, 23880145.
2. Kwiatkowski DJ, Stossel TP, Orkin SH, Mole JE, Colten HR, Yin HL. Plasma and cytoplasmic gelsolins are encoded by a single gene and contain a duplicated actin-binding domain. Nature 1986, 323:455-458. 10.1038/323455a0, 3020431.
3. Yin HL, Kwiatkowski DJ, Mole JE, Cole FS. Structure and biosynthesis of cytoplasmic and secreted variants of gelsolin. J Biol Chem 1984, 259:5271-5276.
4. Li GH, Arora PD, Chen Y, McCulloch CA, Liu P. Multifunctional roles of gelsolin in health and diseases. Med Res Rev 2010, [Epub ahead of print].
5. Endres M, Fink K, Zhu J, Stagliano NE, Bondada V, Geddes JW, Azuma T, Mattson MP, Kwiatkowski DJ, Moskowitz MA. Neuroprotective effects of gelsolin during murine stroke. J Clin Invest 1999, 103:347-354. 10.1172/JCI4953, 407902, 9927495.
6. Le HT, Hirko AC, Thinschmidt JS, Grant M, Li Z, Peris J, King MA, Hughes JA, Song S. The protective effects of plasma gelsolin on stroke outcome in rats. Exp Transl Stroke Med 2011, 3:13. 10.1186/2040-7378-3-13, 3224589, 22047744.
7. Lee PS, Patel SR, Christiani DC, Bajwa E, Stossel TP, Waxman AB. Plasma gelsolin depletion and circulating actin in sepsis: a pilot study. PLoS One 2008, 3:e3712. 10.1371/journal.pone.0003712, 2577888, 19002257.
8. Lee PS, Drager LR, Stossel TP, Moore FD, Rogers SO. Relationship of plasma gelsolin levels to outcomes in critically ill surgical patients. Ann Surg 2006, 243:399-403. 10.1097/01.sla.0000201798.77133.55, 1448930, 16495706.
9. Chou SH, Lee PS, Konigsberg RG, Gallacci D, Chiou T, Arai K, Simmons S, Bauer D, Feske SK, Lo EH, Ning MM. Plasma-type gelsolin is decreased in human blood and cerebrospinal fluid after subarachnoid hemorrhage. Stroke 2011, 42:3624-3627. 10.1161/STROKEAHA.111.631135, 3537515, 21940962.
10. Guo XC, Luo BY, Li XF, Yang DG, Zheng XN, Zhang K. Plasma gelsolin levels and 1-year mortality after first-ever ischemic stroke. J Crit Care 2011, 26:608-612. 10.1016/j.jcrc.2011.02.007, 21481565.
11. Zhao DQ, Wang K, Zhang HD, Li YJ. Significant reduction of plasma gelsolin levels in patients with intracerebral hemorrhage. Clin Chim Acta 2013, 415:202-206.
12. Chou SH, Feske SK, Simmons SL, Konigsberg RG, Orzell SC, Marckmann A, Bourget G, De Jager PL, Du R, Arai K, Lo EH, Ning MM. Elevated peripheral neutrophils and matrix metalloproteinase 9 as biomarkers of functional outcome following subarachnoid hemorrhage. Transl Stroke Res 2011, 2:600-607. 10.1007/s12975-011-0117-x, 3236293, 22207885.